Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Spark Therapeutics

Explore full profile

A fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia

Philadelphia, United StatesFounded 2013Biotech & Life Sciences
Valuation $4.30B Market cap · 2019
Revenue $65M Latest reported FY

About Spark Therapeutics

Spark Therapeutics is a leading biotechnology company specializing in gene therapy solutions aimed at treating genetic diseases. The company operates in the healthcare and biotechnology market, focusing on developing transformative treatments that address the underlying causes of genetic disorders. Spark Therapeutics serves a diverse range of clients, including healthcare providers, patients, and research institutions. The business model revolves around research and development (R&D), clinical trials, and commercialization of gene therapy products. Revenue is generated through product sales, partnerships, and licensing agreements. Spark Therapeutics is committed to innovation and improving patient outcomes through cutting-edge gene therapy techniques.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2013
Headquarters
Philadelphia, United States
Listing
IPO 2015
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierColt$25–100M revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • The Children's Hospital of Philadelphia
  • Sofinnova Investments

Series B and later3 investors entered at this stage

  • University of Pennsylvania
  • The Children's Hospital of Philadelphia
  • Sofinnova Investments

Talent

Book a demo to see the people
Employees mapped 292 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States97%
🇩🇴 Dominican Republic0.5%
🇨🇦 Canada0.5%
🇿🇦 South Africa0.5%
🇳🇱 Netherlands0.5%
Top 5 of 6 shown
Web traffic by country
1.8K monthly visits
across markets
🇺🇸 United States83.3%
🇮🇳 India16.7%
Top 2 markets shown

Patents

Estimated portfolio value
$46M

40 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Spark Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Spark Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles